申请人:Bayer Aktiengesellschaft
公开号:US05470982A1
公开(公告)日:1995-11-28
For the treatment of lipoproteinaemia and arteriosclerosis, the new disubstituted pyridines of the formula ##STR1## in which R.sup.1 is optionally substituted aryl or heteroaryl, R.sup.2 is cycloalkyl or optionally substituted alkyl, R.sup.3 is hydrogen, cycloalkyl, or optionally substituted alkyl, aryl or heteroaryl, X is --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--, A is ##STR2## R.sup.6 is hydrogen or alkyl, and R.sup.7 is hydrogen, alkyl, aralkyl or a cation.
用于治疗脂蛋白血症和动脉硬化的新双取代吡啶的化学式为 ##STR1## 其中 R.sup.1 是可选取代芳基或杂环芳基,R.sup.2 是环烷基或可选取代烷基,R.sup.3 是氢,环烷基或可选取代烷基,芳基或杂环芳基,X 是 --CH.sub.2 --CH.sub.2 -- 或 --CH.dbd.CH--, A 是 ##STR2## R.sup.6 是氢或烷基,R.sup.7 是氢,烷基,芳基烷基或阳离子。